Antibiotic Stewardship in der Intensivmedizin

Antibiotic-Stewardship-Programme wollen die Versorgungsqualität mit Antiinfektiva im ambulanten und stationären Bereich optimieren. Ziel sind „beste klinische Behandlungsergebnisse“ mit „Minimierung von Toxizität, […] Resistenzentwicklung und Kosten“ [1]. Dabei bewegt sich das ABS-Team manchmal im Spannungsfeld zwischen ärztlicher Therapiefreiheit und rationalen Überlegungen. Neben Fachwissen ist daher auch Kommunikationskompetenz erforderlich.

• Literatur

• 1 de With K, Allerberger F, Amann S. et al. Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases. Infection 2016; 44: 395-439
• 2 Bundesamt für Verbraucherschutz und Lebensmittelsicherheit, Paul-Ehrlich-Gesellschaft für Chemotherapie e.V.. (Hrsg). GERMAP 2015 – Bericht über den Antibiotikaverbrauch und die Verbreitung von Antibiotikaresistenzen in der Human- und Veterinärmedizin in Deutschland. Rheinbach: Antiinfectives Intelligence; 2016
• 3 Dalhoff K, Abele-Horn M, Andreas S. et al. Epidemiology, Diagnosis and Treatment of Adult Patients with Nosocomial Pneumonia – Update 2017 – S3 Guideline of the German Society for Anaesthesiology and Intensive Care Medicine, the German Society for Infectious Diseases, the German Society for Hygiene and Microbiology, the German Respiratory Society and the Paul-Ehrlich-Society for Chemotherapy, the German Radiological Society and the Society for Virology. Pneumologie 2018; 72: 15-63
• 4 Rhee C. Using procalcitonin to guide antibiotic therapy. Open Forum Infect Dis 2017; 4: ofw249
• 5 Oliveira CF, Botoni FA, Oliveira CRA. et al. Procalcitonin versus C-reactive protein for guiding antibiotic therapy in sepsis: a randomized trial. Crit Care Med 2013; 41: 2336-2343
• 6 Azuhata T, Kinoshita K, Kawano D. et al. Time from admission to initiation of surgery for source control is a critical determinant of survival in patients with gastrointestinal perforation with associated septic shock. Critical Care 2014; 18: R87
• 7 Jensen JU, Heslet L, Jensen TH. et al. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Critical Care Medicine 2006; 34: 2596
• 8 Jensen JU, Hein L, Lundgren B. et al. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: A randomized trial. Critical Care Medicine 2011; 39: 2048
• 9 Fätkenheuer G, Jung N, Kern WV. et al. Infektiologie – ein Schwerpunkt der Inneren Medizin. Internist 2018; 59: 334-340
• 10 Vardakas KZ, Voulgaris GL, Maliaros A. et al. Prolonged versus short-term intravenous infusion of antipseudomonal β-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials. Lancet Infect Dis 2018; 18: 108-120
• 11 Muller AE, Huttner B, Huttner A. Therapeutic drug monitoring of beta-lactams and other antibiotics in the intensive care unit: which agents, which patients and which infections?. Drugs 2018; 78: 439-451
• 12 MacFadden DR, LaDelfa A, Leen J. et al. Impact of reported beta-lactam allergy on inpatient outcomes: A multicenter prospective cohort study. Clin Infect Dis 2016; 63: 904-910
• 13 Huang KHG, Cluzet V, Hamilton K. et al. The impact of reported beta-lactam allergy in hospitalized patients with hematologic malignancies requiring antibiotics. Clin Infect Dis 2018 [epub ahead of print]
• 14 Davey P, Marwick CA, Scott CL. et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 2017; 2: CD003543
• 15 Schuts EC, Hulscher MEJL, Mouton JW. et al. Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis. Lancet Infect Dis 2016; 16: 847-856
• 16 Paulsen J, Solligård E, Damås JK. et al. The impact of infectious disease specialist consultation for Staphylococcus aureus bloodstream infections: A systematic review. Open Forum Infect Dis 2016; 3: ofw048
• 17 Baur D, Gladstone BP, Burkert F. et al. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. Lancet Infect Dis 2017; 17: 990-1001
• 18 van Duijn PJ, Verbrugghe W, Jorens PG. et al. SATURN consortium. The effects of antibiotic cycling and mixing on antibiotic resistance in intensive care units: a cluster-randomised crossover trial. Lancet Infect Dis 2018; 18: 401-409
• 19 Morgan DJ, Malani P, Diekema DJ. Diagnostic stewardship-leveraging the laboratory to improve antimicrobial use. JAMA 2017; 318: 607-608
• 20 ARS – Antibiotika Resistenz Surveillance. Im Internet: https://ars.rki.de/ (Stand: 06.06.2018)